Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Leukemia, Myelocytic, Acute
|
6892 | 0.590 | 0.760 | 12 | 68158742 | intron variant | T/A | snv | 0.36 | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||
Malignant neoplasm of breast
|
3417 | 0.590 | 0.760 | 12 | 68158742 | intron variant | T/A | snv | 0.36 | 0.020 | 1.000 | 2 | 2014 | 2014 | |||||
Schizophrenia
|
2897 | 0.590 | 0.760 | 12 | 68158742 | intron variant | T/A | snv | 0.36 | 0.020 | 1.000 | 2 | 2013 | 2017 | |||||
Breast Carcinoma
|
2793 | 0.590 | 0.760 | 12 | 68158742 | intron variant | T/A | snv | 0.36 | 0.020 | 1.000 | 2 | 2014 | 2014 | |||||
Rheumatoid Arthritis
|
2387 | 0.590 | 0.760 | 12 | 68158742 | intron variant | T/A | snv | 0.36 | 0.020 | 0.500 | 2 | 2012 | 2019 | |||||
Malignant Neoplasms
|
1641 | 0.590 | 0.760 | 12 | 68158742 | intron variant | T/A | snv | 0.36 | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||
Coronary Artery Disease
|
1577 | 0.590 | 0.760 | 12 | 68158742 | intron variant | T/A | snv | 0.36 | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||
Asthma
|
1536 | 0.590 | 0.760 | 12 | 68158742 | intron variant | T/A | snv | 0.36 | 0.010 | 1 | 2014 | 2014 | ||||||
Primary malignant neoplasm
|
1374 | 0.590 | 0.760 | 12 | 68158742 | intron variant | T/A | snv | 0.36 | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||
Coronary heart disease
|
1178 | 0.590 | 0.760 | 12 | 68158742 | intron variant | T/A | snv | 0.36 | 0.010 | 1 | 2013 | 2013 | ||||||
Lupus Erythematosus, Systemic
|
1172 | 0.590 | 0.760 | 12 | 68158742 | intron variant | T/A | snv | 0.36 | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||
Prostate carcinoma
|
1168 | 0.590 | 0.760 | 12 | 68158742 | intron variant | T/A | snv | 0.36 | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||
Crohn Disease
|
1147 | 0.590 | 0.760 | 12 | 68158742 | intron variant | T/A | snv | 0.36 | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||
Malignant neoplasm of prostate
|
1082 | 0.590 | 0.760 | 12 | 68158742 | intron variant | T/A | snv | 0.36 | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||
Liver carcinoma
|
942 | 0.590 | 0.760 | 12 | 68158742 | intron variant | T/A | snv | 0.36 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
Bipolar Disorder
|
839 | 0.590 | 0.760 | 12 | 68158742 | intron variant | T/A | snv | 0.36 | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||
Ulcerative Colitis
|
827 | 0.590 | 0.760 | 12 | 68158742 | intron variant | T/A | snv | 0.36 | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||
Ankylosing spondylitis
|
609 | 0.590 | 0.760 | 12 | 68158742 | intron variant | T/A | snv | 0.36 | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||
Inflammatory Bowel Diseases
|
605 | 0.590 | 0.760 | 12 | 68158742 | intron variant | T/A | snv | 0.36 | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||
Metabolic Syndrome X
|
591 | 0.590 | 0.760 | 12 | 68158742 | intron variant | T/A | snv | 0.36 | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||
Hepatitis B
|
519 | 0.590 | 0.760 | 12 | 68158742 | intron variant | T/A | snv | 0.36 | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||
Hepatitis C
|
347 | 0.590 | 0.760 | 12 | 68158742 | intron variant | T/A | snv | 0.36 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
Tuberculosis
|
328 | 0.590 | 0.760 | 12 | 68158742 | intron variant | T/A | snv | 0.36 | 0.060 | 1.000 | 6 | 2010 | 2017 | |||||
Cervix carcinoma
|
283 | 0.590 | 0.760 | 12 | 68158742 | intron variant | T/A | snv | 0.36 | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||
cervical cancer
|
268 | 0.590 | 0.760 | 12 | 68158742 | intron variant | T/A | snv | 0.36 | 0.010 | 1.000 | 1 | 2015 | 2015 |